Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Accendra Health (ACH) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Accendra Health (ACH) over the last 17 years, with Q3 2025 value amounting to $455.2 million.

  • Accendra Health's Other Accumulated Expenses rose 37.18% to $455.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $455.2 million, marking a year-over-year increase of 37.18%. This contributed to the annual value of $294.7 million for FY2024, which is 2571.61% down from last year.
  • Latest data reveals that Accendra Health reported Other Accumulated Expenses of $455.2 million as of Q3 2025, which was up 37.18% from $421.7 million recorded in Q2 2025.
  • In the past 5 years, Accendra Health's Other Accumulated Expenses ranged from a high of $455.2 million in Q3 2025 and a low of $206.1 million during Q3 2021
  • For the 5-year period, Accendra Health's Other Accumulated Expenses averaged around $361.5 million, with its median value being $396.7 million (2023).
  • In the last 5 years, Accendra Health's Other Accumulated Expenses plummeted by 5003.58% in 2021 and then surged by 7654.21% in 2022.
  • Quarter analysis of 5 years shows Accendra Health's Other Accumulated Expenses stood at $226.2 million in 2021, then surged by 36.09% to $307.8 million in 2022, then increased by 28.86% to $396.7 million in 2023, then fell by 25.72% to $294.7 million in 2024, then skyrocketed by 54.47% to $455.2 million in 2025.
  • Its last three reported values are $455.2 million in Q3 2025, $421.7 million for Q2 2025, and $442.1 million during Q1 2025.